
Spontaneous Mouse Tumor-derived Syngeneic Models
Spontaneous mouse tumor-derived syngeneic models are valuable tools in preclinical cancer research. These tumor models offer unique advantages because immunotherapies...
Continue ReadingSpontaneous mouse tumor-derived syngeneic models are valuable tools in preclinical cancer research. These tumor models offer unique advantages because immunotherapies...
Continue ReadingT-cell engagers (TCEs) are a class of bispecific antibody-based immunotherapies designed to bring T cells into close proximity with cancer...
Continue ReadingAntibody-drug conjugates (ADCs) are increasingly demonstrating their value in cancer treatment, especially in combination therapies and for targeting resistant cancer...
Continue ReadingStudies have demonstrated that obesity can promote cancer progression through mechanisms that include chronic low-grade inflammation. Previous research with diet-induced...
Continue ReadingNatural killer (NK) cells play a crucial role in the immune system and can recognize and kill cancer cells. Research...
Continue ReadingAntibody-Drug Conjugates (ADCs) have made significant advancements in cancer treatment, particularly for solid tumors. The bystander effect of ADCs, where...
Continue ReadingCancers, like cervical cancer and head & neck cancer, are strongly linked to human papillomavirus (HPV) infection. Targeting the HPV...
Continue ReadingFrom April 25 to 30, 2025, the annual meeting of the American Association for Cancer Research (AACR), one of the...
Continue ReadingAt this year’s annual meeting of the American Association for Cancer Research (AACR), WuXi Biology has been selected to present...
Continue Reading